These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38694513)

  • 1. Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients.
    Pérez-Díez A; Liu X; Calderon S; Bennett A; Lisco A; Kellog A; Galindo F; Memoli MJ; Rocco JM; Epling BP; Laidlaw E; Sneller MC; Manion M; Wortmann GW; Poon R; Kumar P; Sereti I
    Front Immunol; 2024; 15():1352330. PubMed ID: 38694513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and pathogenicity of autoantibodies in patients with idiopathic CD4 lymphopenia.
    Perez-Diez A; Wong CS; Liu X; Mystakelis H; Song J; Lu Y; Sheikh V; Bourgeois JS; Lisco A; Laidlaw E; Cudrici C; Zhu C; Li QZ; Freeman AF; Williamson PR; Anderson M; Roby G; Tsang JS; Siegel R; Sereti I
    J Clin Invest; 2020 Oct; 130(10):5326-5337. PubMed ID: 32634122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential occurrence of IgM, IgM/IgG, and gp120-IgM/IgG complement complexes on CD4+ lymphocytes in relation to CD4+ blood lymphocyte depletion in HIV+ hemophilia patients: results of a 10-year study.
    Daniel V; Süsal C; Weimer R; Zipperle S; Kröpelin M; Zimmermann R; Huth-Kühne A; Opelz G
    Immunol Lett; 1995; 47(1-2):97-102. PubMed ID: 8537109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
    Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
    Front Immunol; 2020; 11():596684. PubMed ID: 33362779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID-19 patients.
    Marcos-Jiménez A; Sánchez-Alonso S; Alcaraz-Serna A; Esparcia L; López-Sanz C; Sampedro-Núñez M; Mateu-Albero T; Sánchez-Cerrillo I; Martínez-Fleta P; Gabrie L; Del Campo Guerola L; Rodríguez-Frade JM; Casasnovas JM; Reyburn HT; Valés-Gómez M; López-Trascasa M; Martín-Gayo E; Calzada MJ; Castañeda S; de la Fuente H; González-Álvaro I; Sánchez-Madrid F; Muñoz-Calleja C; Alfranca A
    Eur J Immunol; 2021 Mar; 51(3):634-647. PubMed ID: 33251605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies stabilize neutrophil extracellular traps in COVID-19.
    Zuo Y; Yalavarthi S; Navaz SA; Hoy CK; Harbaugh A; Gockman K; Zuo M; Madison JA; Shi H; Kanthi Y; Knight JS
    JCI Insight; 2021 Aug; 6(15):. PubMed ID: 34166229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Levels of Peripheral CD3
    Aljabr W; Al-Amari A; Abbas B; Karkashan A; Alamri S; Alnamnakani M; Al-Qahtani A
    Microbiol Spectr; 2022 Feb; 10(1):e0084521. PubMed ID: 35196808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunological characteristics in COVID-19 convalescent patients.
    Su Z; Hu W; Liu Q; Zhang Y; Chen T; Zhou Y; Zhang Z; Chen Y; Yang R; Xiong Y; Wang X
    Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2669-2676. PubMed ID: 34625887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression.
    Mahmoodpoor A; Hosseini M; Soltani-Zangbar S; Sanaie S; Aghebati-Maleki L; Saghaleini SH; Ostadi Z; Hajivalili M; Bayatmakoo Z; Haji-Fatahaliha M; Babaloo Z; Farid SS; Heris JA; Roshangar L; Rikhtegar R; Kafil HS; Yousefi M
    Mol Immunol; 2021 Oct; 138():121-127. PubMed ID: 34392110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques.
    Hasenkrug KJ; Feldmann F; Myers L; Santiago ML; Guo K; Barrett BS; Mickens KL; Carmody A; Okumura A; Rao D; Collins MM; Messer RJ; Lovaglio J; Shaia C; Rosenke R; van Doremalen N; Clancy C; Saturday G; Hanley P; Smith BJ; Meade-White K; Shupert WL; Hawman DW; Feldmann H
    mBio; 2021 Aug; 12(4):e0150321. PubMed ID: 34311582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+ lymphocyte decrease in HIV disease: association with anti-CD4+ but not with anti-CD8+ lymphocyte autoantibodies.
    Daniel V; Süsal C; Weimer R; Zipperle S; Kröpelin M; Zimmermann R; Huth-Kühne A; Gerhard I; Maier H; Opelz G
    Vox Sang; 1996; 70(2):86-91. PubMed ID: 8801768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotype and cytotoxicity spectra of anti-lymphocyte antibodies in patients with systemic lupus erythematosus.
    Edwards BS; Searles RP; Brozek CM; Richards R; Savage SM; Nolla H; Hoffman CL
    Clin Immunol Immunopathol; 1987 Dec; 45(3):333-47. PubMed ID: 3315337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray-Based Detection of Antibodies against SARS-CoV-2 Proteins, Common Respiratory Viruses and Type I Interferons.
    Savvateeva E; Filippova M; Valuev-Elliston V; Nuralieva N; Yukina M; Troshina E; Baklaushev V; Ivanov A; Gryadunov D
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune cell profiling and antibody responses in patients with COVID-19.
    Rezaei M; Mahmoudi S; Mortaz E; Marjani M
    BMC Infect Dis; 2021 Jul; 21(1):646. PubMed ID: 34225645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of T cell dysfunction with the presence of IgG autoantibodies on CD4+ lymphocytes in haemophilia patients; results of a 10-year study.
    Daniel V; Süsal C; Weimer R; Zipperle S; Kröpelin M; Zimmermann R; Huth-Kühne A; Opelz G
    Clin Exp Immunol; 1996 Apr; 104(1):4-10. PubMed ID: 8603531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2-Specific Antibody and T Cell Response Kinetics According to Symptom Severity.
    Kim JY; Kwon JS; Bae S; Cha HH; Lim JS; Kim MC; Chung JW; Park SY; Lee MJ; Kim BN; Jung J; Kim MJ; Shin EC; Kim SH
    Am J Trop Med Hyg; 2021 Jun; 105(2):395-400. PubMed ID: 34143752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4
    Popescu I; Snyder ME; Iasella CJ; Hannan SJ; Koshy R; Burke R; Das A; Brown MJ; Lyons EJ; Lieber SC; Chen X; Sembrat JC; Bhatt P; Deng E; An X; Linstrum K; Kitsios G; Konstantinidis I; Saul M; Kass DJ; Alder JK; Chen BB; Lendermon EA; Kilaru S; Johnson B; Pilewski JM; Kiss JE; Wells AH; Morris A; McVerry BJ; McMahon DK; Triulzi DJ; Chen K; Sanchez PG; McDyer JF
    Am J Respir Crit Care Med; 2022 Jun; 205(12):1403-1418. PubMed ID: 35348444
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of antibody responses to SARS-CoV-2 in convalescent COVID-19 patients.
    Liu C; Yu X; Gao C; Zhang L; Zhai H; Hu Y; Liu E; Wang Q; Gao Y; Wei D; Zhang D; Han Y; Zhang X
    J Med Virol; 2021 Apr; 93(4):2227-2233. PubMed ID: 33135795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild Cytokine Elevation, Moderate CD4
    Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J
    Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.